Glycine supplement for fatty liver disease
Part of Digestive system clinical trials.
This trial studies whether a supplement called glycine (an amino acid) can help improve fatty liver disease. It involves taking the supplement daily and doing MRI scans to see if the fat in your liver changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 70 years old
- You have fatty liver disease confirmed by an MRI, and your BMI is between 25 and 50
- You do not have diabetes that is not well controlled (HbA1c > 8%), type 1 diabetes, or significant anemia
- You do not have other chronic liver diseases (like hepatitis B or C, cirrhosis) or take medications that can cause fatty liver (like methotrexate, tamoxifen, or certain steroids)
- You have not had weight loss surgery, have not recently lost more than 5% of your weight, and are not taking weight-loss medications
- You are not pregnant and do not have metal implants (like certain pacemakers) or severe claustrophobia that would prevent an MRI scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether aspirin can help people with MASLD, a type of fatty liver disease linked to conditions like diabetes and obesity. It aims to see if aspirin can improve liver health without causing harm.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether a supplement called betaine can reduce liver fat and damage in people with a type of fatty liver disease that includes inflammation. Half of the participants will receive betaine, and half will receive a placebo (a pill with no active ingredient).
This study tests whether a special supplement (made from cacao, nopal, and crickets) can help improve fatty liver disease in people with excess body fat. Fatty liver disease happens when fat builds up in the liver, and this trial investigates whether these natural ingredients can reduce that buildup.
This trial is testing whether taking a special form of vitamin B9 (called 5-methyltetrahydrofolate) can improve fatty liver disease. If you have mild to moderate fatty liver and are overweight, this supplement might help reduce liver fat and improve your health.
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.